tiprankstipranks
Regen Biopharma (RGBP)
OTHER OTC:RGBP
US Market

Regen Biopharma (RGBP) Income Statement

Compare
118 Followers

Regen Biopharma Income Statement

Last quarter (Q3 2024), Regen Biopharma's total revenue was $59.06K, an increase of 0.59% from the same quarter last year. In Q3, Regen Biopharma's net income was $-117.11K. See Regen Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
$ 236.56K$ 235.52K$ 171.19K$ 110.00K$ 110.00K
Gross Profit
$ 236.56K$ 185.52K$ 146.19K$ 110.00K$ 110.00K
Operating Expenses
$ 923.51K$ 575.12K$ 371.96K$ 319.32K$ 866.78K
Depreciation and Amortization
$ 1.90M$ 339.61K$ 200.77K$ 209.32K$ 874.91K
EBITDA
$ 1.22M$ 2.99M$ -6.40M$ 4.36M$ -753.75K
Operating Income
$ -686.95K$ -339.61K$ -200.77K$ -209.32K$ -756.78K
Other Income/Expenses
$ 1.84M$ 2.78M$ -6.56M$ 3.62M$ -1.87M
Pretax Income
$ 1.16M$ 2.44M$ -6.77M$ 3.41M$ -2.62M
Net Income
$ 1.02M$ 5.49M$ -7.13M$ 1.79M$ -4.32M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.29$ 1.75$ -3.55$ 1.90$ -3.13
Diluted EPS
$ 0.29$ 1.75$ -3.55$ 1.90$ -3.13
Weighted Average Shares Outstanding
3.54M 3.14M 2.01M 939.90K 1.38M
Weighted Average Shares Outstanding (Diluted)
3.54M 3.14M 2.01M 939.90K 1.38M
Currency in USD

Regen Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis